Stockreport

Zevra Reports Third Quarter 2025 Financial Results and Corporate Update

Zevra Therapeutics, Inc.  (ZVRA) 
PDF 2025 EPS of $(0.01) Q3 2025 net revenue of $26.1 million, driven by MIPLYFFA® net revenue of $22.4 million Company to host conference call and webcast TODAY, November  [Read more]